Please assess the completion status of the following clinical trial:

Trial Title: Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed AS patients.~  * 18 years old~* Did not receive previous biological treatment for any reason~Exclusion Criteria:~* Patients previously or currently treated with other biological therapies.~* Use of etanercept for less than 1 year duration.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients with ankylosing spondylitis (Type: None): Iraqi patients diagnosed with ankylosing spondylitis that received Etanercept as treatment for disease

Based on this trial design, predict the completion outcome and termination type (if applicable).